Tyrosine phosphorylation / dephosphorylation balance is involved in thrombin-evoked microtubular reorganisation in human platelets

Summary

We have investigated the intracellular mechanisms involved in microtubular remodelling by thrombin and its possible involvement in platelet aggregation and secretion. Platelet stimulation with thrombin induces a time- and concentration-dependent regulation of the microtubular content, which was found to be maximally effective at the concentration 0.1 U/ml. Thrombin (0.1 U/ml) evoked an initial decrease in the microtubule content detectable at 5 seconds (sec) and reached a minimum 10 sec after stimulation.The microtubular content then increased, exceeding basal levels again approximately 30 sec after stimulation. Inhibition of tyrosine phosphatases using vanadate abolished thrombin-induced microtubular depolymerisation while inhibition of tyrosine kinases by methyl-2,5-dihydroxycinnamate prevented microtubule polymerisation.Thrombin activates the cytosolic Brutons tyrosine kinase (Btk) and Src proteins. Inhibition of Btk or Src by LFM-A13 or PP1, respectively, abolished thrombin-induced microtubular polymerisation, while maintaining intact its ability to induce initial depolymerisation. Microtubular disruption by colchicine significantly reduced thrombin induced platelet aggregation and ATP secretion. Similar results were observed after inhibition of microtubular disassembly by paclitaxel.These findings indicate that thrombin induces microtubular remodelling by modifying the balance between protein tyrosine phosphorylation and dephosphorylation. The former seems to be required for microtubular polymerisation, while tyrosine dephosphorylation is required for microtubular depolymerisation. Both, initial microtubular disassembly and subsequent polymerisation are required for thrombin-induced platelet aggregation and secretion in human platelets.

Keywords

Thrombin - microtubules - aggregation - platelets - pp60^src - Btk - protein kinases - protein phosphatases - ATP

• References

• 1 Wiese C, Zheng Y. Microtubule nucleation: gamma-tubulin and beyond. J Cell Sci 2006; 119: 4143-4153.
• 2 Desai A, Mitchison TJ. Microtubule polymerization dynamics. Annu Rev Cell Dev Biol 1997; 13: 83-117.
• 3 Behnke O. Microtubules in disk-shaped blood cells. Int Rev Exp Pathol 1970; 9: 1-92.
• 4 Stephens RE. Membrane tubulin. Biol Cell 1986; 57: 95-109.
• 5 Gearhart DA, Sickles DW, Buccafusco JJ. et al. Chlorpyrifos, chlorpyrifos-oxon, and diisopropylfluorophosphate inhibit kinesin-dependent microtubule motility. Toxicol Appl Pharmacol 2007; 218: 20-29.
• 6 Reed NA, Cai D, Blasius TL. et al. Microtubule acetylation promotes kinesin-1 binding and transport. Curr Biol 2006; 16: 2166-2172.
• 7 Northover AM, Northover BJ. Possible involvement of microtubules in platelet-activating factor-induced increases in microvascular permeability in vitro. Inflammation 1993; 17: 633-639.
• 8 Kenney DM, Chao FC. Microtubule inhibitors alter the secretion of beta-glucuronidase by human blood platelets: involvement of microtubules in release reaction II. J Cell Physiol 1978; 96: 43-52.
• 9 Martin JF, Holland TK, Russell RG. Evidence for the involvement of microtubules in the ADP-induced secretion in platelet 14C-5-hydroxytryptamine. Thromb Res 1981; 22: 525-533.
• 10 Sneddon JM. Effect of mitosis inhibitors on blood platelet microtubules and aggregation. J Physiol 1971; 214: 145-158.
• 11 Hashizume T, Akiba S, Sato T. et al. Vinblastine inhibits platelet aggregation by a microtubule-independent mechanism, probably by its perturbing action on the plasma membrane. Thromb Res 1988; 50: 181-190.
• 12 Jung SM, Yamazaki H, Tetsuka T. et al. Effect of nocodazole, a new microtubule inhibitor, on platelet aggregation and release. Thromb Res 1981; 23: 401-410.
• 13 Huby RD, Weiss A, Ley SC. Nocodazole Inhibits Signal Transduction by the T Cell Antigen Receptor. J Biol Chem 1998; 273: 12024-12031.
• 14 Ribbi-Jaffe A, Apitz-Castro R. The effect of colchicine on human blood platelets under conditions of short-term incubation. Biochem J 1979; 178: 449-454.
• 15 Canizares C, Vivar N, Herdoiza M. Role of the microtubular system in platelet aggregation. Braz J Med Biol Res 1994; 27: 1533-1551.
• 16 Kahn ML, Zheng Y, Huang W. et al. A dual thrombin receptor system for platelet activation. Nature 1998; 394: 690-694.
• 17 Lova P, Campus F, Lombardi R. et al. Contribution of protease-activated receptors 1 and 4 and glycoprotein Ib-IX-V in the G(i)-independent activation of platelet Rap1B by thrombin. J Biol Chem 2004; 279: 25299-25306.
• 18 Jardin I, Ben Amor N, Bartegi A. et al. Differential involvement of thrombin receptors in Ca2+ release from two different intracellular stores in human platelets. Biochem J 2007; 401: 167-174.
• 19 Golden A, Brugge JS. Thrombin treatment induces rapid changes in tyrosine phosphorylation in platelets. Proc Natl Acad Sci USA 1989; 86: 901-905.
• 20 Clark EA, Shattil SJ, Brugge JS. Regulation of protein tyrosine kinases in platelets. Trends Biochem Sci 1994; 19: 464-469.
• 21 Rosado JA, Porras T, Conde M. et al. Cyclic nucleotides modulate store-mediated calcium entry through the activation of protein-tyrosine phosphatases and altered actin polymerization in human platelets. J Biol Chem 2001; 276: 15666-15675.
• 22 Redondo PC, Ben-Amor N, Salido GM. et al. Ca2+-independent activation of Bruton’s tyrosine kinase is required for store-mediated Ca2+ entry in human platelets. Cell Signal 2005; 17: 1011-1021.
• 23 Redondo PC, Jardin I, Hernandez-Cruz JM. et al. Hydrogen peroxide and peroxynitrite enhance Ca2+ mobilization and aggregation in platelets from type 2 diabetic patients. Biochem Biophys Res Commun 2005; 333: 794-802.
• 24 Rosado JA, Sage SO. Farnesylcysteine analogues inhibit store-regulated Ca2+ entry in human platelets: evidence for involvement of small GTP-binding proteins and actin cytoskeleton. Biochem J 2000; 347: 183-192.
• 25 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
• 26 Diaz JF, Strobe R, Engelborghs Y. et al. Molecular recognition of taxol by microtubules. Kinetics and thermodynamics of binding of fluorescent taxol derivatives to an exposed site. J Biol Chem 2000; 275: 26265-26276.
• 27 Dreier L, Rapoport TA. In vitro formation of the endoplasmic reticulum occurs independently of microtubules by a controlled fusion reaction. J Cell Biol 2000; 148: 883-898.
• 28 Kawakami Y, Hartman SE, Kinoshita E. et al. Terreic acid, a quinone epoxide inhibitor of Bruton’s tyrosine kinase. Proc Natl Acad Sci USA 1999; 96: 2227-2232.
• 29 Rawlings DJ, Scharenberg AM, Park H. et al. Activation of BTK by a phosphorylation mechanism initiated by SRC family kinases. Science 1996; 271: 822-825.
• 30 Nisitani S, Kato RM, Rawlings DJ. et al. In situ detection of activated Bruton’s tyrosine kinase in the Ig signaling complex by phosphopeptide-specific monoclonal antibodies. Proc Natl Acad Sci USA 1999; 96: 2221-2226.
• 31 Waltenberger J, Uecker A, Kroll J. et al. A dual inhibitor of platelet-derived growth factor β-receptor and Src kinase activity potently interferes with motogenic and mitogenic responses to PDGF in vascular smooth muscle cells. A novel candidate for prevention of vascular remodeling. Circ Res 1999; 85: 12-22.
• 32 Osusky M, Taylor SJ, Shalloway D. Autophosphorylation of purified c-Src at its primary negative regulation site. J Biol Chem 1995; 270: 25729-25732.
• 33 Fernandez-Veledo S, Huber-Ruano I, Aymerich I. et al. Bile acids alter the subcellular localization of CNT2 (concentrative nucleoside cotransporter) and increase CNT2-related transport activity in liver parenchymal cells. Biochem J 2006; 395: 337-344.
• 34 Parise LV, Smyth SS, Coller BS. Platelet morphology, biochemistry, and function. In: Williams Hematology. Mc Graw-Hill; New York: 2001: 1357-1408.
• 35 Hemker HC, Al Dieri R, De Smedt E. et al. Thrombin generation, a function test of the haemostatic-thrombotic system. Thromb Haemost 2006; 96: 553-561.
• 36 Weitz JI. Emerging anticoagulants for the treatment of venous thromboembolism. Thromb Haemost 2006; 96: 274-284.
• 37 Vretenbrant K, Ramstrom S, Bjerke M. et al. Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development. Thromb Haemost 2007; 97: 417-424.
• 38 Escolar G, Sauk J, Bravo ML. et al. Immunogold staining of microtubules in resting and activated platelets. Am J Hematol 1987; 24: 177-188.
• 39 Fuste B, Diaz-Ricart M, Jensen MK. et al. TRAP induces more intense tyrosine phosphorylation than thrombin with differential ultrastructural features. Am J Pathol 2002; 160: 2245-2252.
• 40 Fernandez-Patron C, Zhang Y, Radomski MW. et al. Rapid release of matrix metalloproteinase (MMP)-2 by thrombin in the rat aorta: modulation by protein tyrosine kinase/phosphatase. Thromb Haemost 1999; 82: 1353-1357.
• 41 Torti M, Festetics ET, Bertoni A. et al. Clustering of integrin alphaIIb-beta3 differently regulates tyrosine phosphorylation of pp72syk, PLCgamma2 and pp125FAK in concanavalin A-stimulated platelets. Thromb Haemost 1999; 81: 124-130.
• 42 Hirsch E, Lembo G, Montrucchio G. et al. Signaling through PI3Kgamma: a common platform for leukocyte, platelet and cardiovascular stress sensing. Thromb Haemost 2006; 95: 29-35.
• 43 Chiang TM, Woo-Rasberry V, Cole F. Role of platelet endothelial form of nitric oxide synthase in collagen- platelet interaction: regulation by phosphorylation. Biochim Biophys Acta 2002; 1592: 169-174.
• 44 Pampolina C, McNicol A. Streptococcus sanguisinduced platelet activation involves two waves of tyrosine phosphorylation mediated by FcgammaRIIA and alphaIIbbeta3. Thromb Haemost 2005; 93: 932-939.
• 45 Redondo PC, Ben-Amor N, Salido GM. et al. Ca2+-independent activation of Bruton’s tyrosine kinase is required for store-mediated Ca2+ entry in human platelets. Cell Signal 2005; 17: 1011-1021.
• 46 Ben-Amor N, Redondo PC, Bartegi A. et al. A role for 5,6-epoxyeicosatrienoic acid in calcium entry by de novo conformational coupling in human platelets. J Physiol 2006; 570: 309-323.
• 47 Leoncini G, Bruzzese D, Signorello MG. et al. Platelet activation by collagen is increased in retinal vein occlusion. Thromb Haemost 2007; 97: 218-227.
• 48 Riba R, Sharifi M, Farndale RW. et al. Regulation of platelet guanylyl cyclase by collagen: evidence that Glycoprotein VI mediates platelet nitric oxide synthesis in response to collagen. Thromb Haemost 2005; 94: 395-403.
• 49 White JG, Krumwiede M, Burris SM. et al. Isolation of microtubule coils from platelets after exposure to aggregating agents. Am J Pathol 1986; 125: 319-326.
• 50 Falker K, Lange D, Presek P. ADP secretion and subsequent P2Y12 receptor signalling play a crucial role in thrombin-induced ERK2 activation in human platelets. Thromb Haemost 2004; 92: 114-123.
• 51 Muallen S, Kwiatkowska K, Xu X. et al. Actin filament disassembly is a sufficient final trigger for exocytosis in nonexcitable cells. J Cell Biol 1995; 128: 589-598.